Search Results

You are looking at 81 - 90 of 388 items for :

  • Refine by Access: All x
Clear All
Full access


; Adolescents and Young Adults With Cancer; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkin Lymphoma; Lung Cancer Screening; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Nausea and Vomiting; Non-Hodgkin's Lymphomas; Soft Tissue

Full access

Optimizing Patient Care in Chronic Phase Chronic Myelogenous Leukemia: A Multidisciplinary Approach

Hema Sundar and Jerald Radich

taking nilotinib. In addition, her primary care physician was also asked to monitor the patient's blood glucose levels more closely. Her disease responded well to nilotinib, and BCR-ABL1 level decreased to 0.025%. However, she was experiencing nausea

Full access

Psychological Issues in Geriatric Oncology

Archna Sarwal and Andrew J. Roth

. Mirtazapine may be helpful in treating nausea and insomnia of cancer chemotherapy . Support Care Cancer 2001 ; 9 : 469 – 470 . 25 Musselman DL Lawson DH Gumnick JF : Paroxetine for the prevention of depression induced by high

Full access

Palliative Care: Who is Responsible?

Amanda M. Rosenblum and Martin R. Chasen

Canadian Problem Checklist (CPC). The ESAS is a questionnaire that asks patients to rate the severity of 9 common symptoms—pain, fatigue, tiredness, nausea, appetite, shortness of breath, depression, anxiety, and well-being—on a visual analogue scale

Full access


more than 55 different NCCN Guidelines for Patients covering every major type of cancer, along with topics like managing cancer-related distress, nausea and vomiting, and survivorship, plus special considerations for adolescents and young adults across

Full access

Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash

Neelima N. Nallapaneni, Rajesh Mourya, Vijaya Raj Bhatt, Sakshi Malhotra, Apar Kishor Ganti, and Ketki K. Tendulkar

-Induced Immune-Related Adverse Events a Case Report A 62-year-old man presented to the emergency department with nausea and vomiting for 5 days and dizziness for 2 days. His past medical history was significant for BRAF V600E mutation

Full access

Neoadjuvant Imatinib for Borderline Resectable GIST

M. Zach Koontz, Brendan M. Visser, and Pamela L. Kunz

complained of mild fatigue and abdominal fullness occasionally associated with a dull ache in her abdomen. She had no further black stools, nausea, vomiting, or weight loss. Imatinib was initiated at 400 mg daily. Four days later, she presented to the

Full access

Swedish Version of the Distress Thermometer: Validity Evidence in Patients With Colorectal Cancer

Elisabeth Kenne Sarenmalm, Salmir Nasic, Cecilia Håkanson, Joakim Öhlén, Eva Carlsson, Monica E. Pettersson, and Richard Sawatzky

, cognitive, emotional, and social), 3 symptom subscales (fatigue, pain, nausea/vomiting), and 6 single-item scales (dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). The QLQ-C30 also generates a global health status based

Full access

Targeted Therapy in a Young Adult With a Novel Epithelioid Tumor Driven by a PRRC2B-ALK Fusion

Ajay Gupta, Huifei Liu, Kathleen M. Schieffer, Selene C. Koo, Catherine E. Cottrell, Elaine R. Mardis, Ryan D. Roberts, and Nicholas D. Yeager

, nausea, bloating, and vomiting. Imaging studies revealed multiple PET-avid omental masses, the largest measuring 4.9 × 3.5 × 3.9 cm in the central abdomen ( Figure 1 ), and a large amount of ascites. The ascitic fluid was initially negative for tumor

Full access

Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine

Rebecca M. Shulman, David S. Weinberg, Eric A. Ross, Karen Ruth, Glenn F. Rall, Anthony J. Olszanski, James Helstrom, Michael J. Hall, Julia Judd, David Y.T. Chen, Robert G. Uzzo, Timothy P. Dougherty, Riley Williams, Daniel M. Geynisman, Carolyn Y. Fang, Richard I. Fisher, Marshall Strother, Erica Huelsmann, Sunil Adige, Peter D. Whooley, Kevin Zarrabi, Brinda Gupta, Pritish Iyer, Melissa McShane, Hilario Yankey, Charles T. Lee, Nina Burbure, Lauren E. Laderman, Julie Giurintano, Samuel Reiss, and Eric M. Horwitz

second vaccine dose. Vaccine recipients were asked to report whether they had experienced any of the following symptoms: tiredness, local pain or swelling at the injection site, joint pain, muscle pain, fever, chills, headache, nausea, or an allergic